Treatment Outcomes Stratified by Baseline Immunological Status among Young Children Receiving Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Antiretroviral Therapy in Resource‐Limited Settings
1AIDS Working Group, Médecins Sans Frontières; 2Epicentre, Paris, France; and 3Brussels Operational Centre, Médecins Sans Frontières, Brussels, Belgium
A study of 568 children aged <5 years who commenced nonnucleoside reverse‐transcriptase inhibitor–based antiretroviral therapy in resource‐limited settings revealed good early outcomes. After 12 months of antiretroviral therapy, survival probability was 0.89 (95% confidence interval, 0.86–0.92), with no significant difference among children stratified on the basis of baseline immunological levels; 62% attained a CD4 cell percentage >25%, and 7% continued to have a CD4 cell percentage <15%.
Received 26 November 2006; accepted 20 January 2007; electronically published 28 March 2007.
Cited by
Online publication date: 1-Jul-2009.
CrossRef
Online publication date: 1-Apr-2009.
CrossRef
Online publication date: 1-Feb-2009.
CrossRef
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Oct-2008.
CrossRef
Online publication date: 1-Aug-2008.
CrossRef
Online publication date: 1-Aug-2008.
CrossRef
Online publication date: 1-May-2008.
CrossRef
Online publication date: 1-Oct-2007.
CrossRef



